Find and Pitch Jounalists, Get Your Story Covered

Tags: biotech biotechnology Cancer drug development Drug prices

	Profile	Recent Articles on Subject
1	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	The biotech news you need to read today - 12 days ago Element Biosciences raises another massive round - 4 months ago STAT+: More tumult at BIO amid the company’s fourth CEO in four years - 6 months ago How resurrecting extinct species might impact medicine - 7 months ago New data on liquid biopsy for colorectal cancer detection still underwhelms - 7 months ago Lawmakers want to add more Chinese biotechs to defense list - 7 months ago The biotech updates you need to read today - 11 months ago The legal pathway for experimental, ultra-rare disease treatments is rocky and expensive - 11 months ago FDA chastens pet companies over antibiotics - 11 months ago The biotech news you missed from the weekend - 11 months ago Novartis is building a new radioligand plant in China - 11 months ago Today’s biotech news roundup, in under 800 words - 12 months ago A new algorithm unveils CRISPR ‘treasure trove’ - 12 months ago These are the need-to-know biotech stories from this weekend - 12 months ago XBI biotech index rises, giving investors a shred of hope - about 1 year ago Candor on gene therapy, Abiomed is warned, & BTK success in MS - about 1 year ago Want a biotech buyout? Target cancer - about 1 year ago
2	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	California is a life sciences leader. Joe Panetta has been one of its most vocal advocates. - about 1 month ago Who’s winning in biotech’s tight market? - about 2 months ago Astellas’ science chief on the leap into new technologies - 9 months ago PharmaVoice 100s: Entrepreneurs - about 1 year ago Red Jacket: Helen Sabzevari, an immunotherapy pioneer - about 1 year ago
3	Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California BiotechLife SciencesImmunology	STAT+: Genentech, a biotech with a storied past, confronts new turbulence in the present - about 2 months ago STAT+: With biotech in a slump, the industry’s job market is upside down - 12 months ago STAT+: Failed biotech gives a rare peek inside the tough breaks — and tough choices — that led to its demise - about 1 year ago
4	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	BioMarin’s big day today - 2 months ago STAT+: In light of H5N1 outbreak, U.S. in talks with mRNA vaccine makers on bird flu - 6 months ago
5	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Can BioNTech sustain a post-COVID mRNA pipeline? Oncology is the next hope. - 3 months ago Execs from Bayer, Kite and Orca sound off on their launch strategies for cell and gene therapies - 6 months ago 4 offbeat biotechs making a splash in the life sciences - 6 months ago What’s old is new: The revival of a one-time radiotherapy cancer treatment - 7 months ago These biotech hotspots are ripe for IPOs - 8 months ago Black Diamond looks to outwit cancer mutations - 8 months ago
6	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Flagship Pioneering Launches Startup Abiologics to Advance New Class of Biologic Drugs - 4 months ago
7	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Biotech led by J&J veterans launches with $165 million for cancer, autoimmune therapies - 4 months ago STAT+: How biotech investors spot opportunity when stocks are down — and up - 8 months ago STAT+: Biotech FogPharma raises $145 million in anticipation of more clinical trials, pharma partnerships - 8 months ago STAT+: Biotech incubator Curie.Bio graduates its first startup - about 1 year ago STAT+: Life science investors close nearly $6 billion in new funds - about 1 year ago
8	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	A biotech’s binary bet ends badly - 5 months ago STAT+: The inside story of Enhertu’s pan-tumor approval - 7 months ago STAT+: Weed for weight loss, and more from Biotech Land - 7 months ago
9	Sara Novak Discover Magazine Science journalist. Writer DiscoverMag. Sullivan's Island, South Carolina sciencejournalism	The Future of Organ-Chip Technology Is Bright - 5 months ago
10	Mario Aguilar STAT News Reporter at STATnews. Previous engagements noted. Personal views. Brooklyn techhealth care	STAT+: How biotech investors spot opportunity when stocks are down — and up - 8 months ago

Journalists covering biotech-spotlight